Selective degradation of splicing factor CAPERα by anticancer sulfonamides-Reference-Cited by-同舟云学术

Selective degradation of splicing factor CAPERα by anticancer sulfonamides

Published:2017-04-24 Issue:6 Volume:13 Page:675-680
ISSN:1552-4450
Container-title:Nature Chemical Biology
language:en
Short-container-title:Nat Chem Biol

Author:

Uehara Taisuke,Minoshima Yukinori,Sagane Koji^ORCID,Sugi Naoko Hata,Mitsuhashi Kaoru Ogawa,Yamamoto Noboru,Kamiyama Hiroshi,Takahashi Kentaro,Kotake Yoshihiko,Uesugi Mai,Yokoi Akira,Inoue Atsushi,Yoshida Taku,Mabuchi Miyuki,Tanaka Akito,Owa Takashi

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/nchembio.2363.pdf

Reference44 articles.

1. Chen, D., Frezza, M., Schmitt, S., Kanwar, J. & Dou, Q.P. Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives. Curr. Cancer Drug Targets 11, 239–253 (2011).

2. Soucy, T.A. et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 458, 732–736 (2009).

3. Kim, K.B. & Crews, C.M. From epoxomicin to carfilzomib: chemistry, biology, and medical outcomes. Nat. Prod. Rep. 30, 600–604 (2013).

4. Ito, T. et al. Identification of a primary target of thalidomide teratogenicity. Science 327, 1345–1350 (2010).

5. Krönke, J. et al. Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science 343, 301–305 (2014).

Cited by 307 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. E3 ubiquitin ligases and deubiquitinases in colorectal cancer: Emerging molecular insights and therapeutic opportunities;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-12

2. Inducing or enhancing protein-protein interaction to develop drugs: Molecular glues with various biological activity;European Journal of Medicinal Chemistry;2024-11

3. Dynamic interactions drive early spliceosome assembly;Current Opinion in Structural Biology;2024-10

4. Recent advances in anticancer mechanisms of molecular glue degraders: focus on RBM39-dgrading synthetic sulfonamide such as indisulam, E7820, tasisulam, and chloroquinoxaline sulfonamide;Genes & Genomics;2024-09-13

5. Cullin-RING Ligase 4 in Cancer: Structure, Functions, and Mechanisms;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09